期刊文献+

胃印戒细胞癌组织中p53和HER-2表达及其临床意义 被引量:3

Expression and clinical significance of p53 and Her2 in gastric signet cell carcinoma
原文传递
导出
摘要 目的研究p53和HER-2在胃印戒细胞癌中的表达及其临床意义。方法用免疫组化方法分析60例胃印戒细胞癌p53和HER-2的表达及其与临床病理的关系。结果 p53和HER-2蛋白在胃印戒细胞癌中的表达率分别为48.33%(29/60)和23.33%(14/60)。p53和HER-2的表达与肿瘤大小、浸润深度、淋巴结转移相关(P<0.05),而与年龄、肿瘤部位无相关(P>0.05)。结论 p53和HER-2蛋白表达可能与胃印戒细胞的生长及淋巴结转移相关。 Objective To study the expressions of p53 and HER-2 in gastric signet cell carcinoma. Methods The expressions of p53 and HER-2 were detected in 60 cases with gastric signet cell carcinoma.The relation between the expressions of p53 and HER-2 and clinical pathological charactistics were analyzed as well. Results The positive expression rates of p53 and HER-2 were 48.33%(29/60) and 23.33%(14/60) respectively.The expressions of p53 and HER-2 were correlated to the size,invantion and lymph node metastasis of the tumor(P0.05),but not associated to age of patients and tumor location(P0.05). Conclusion The expressions of p53 and HER-2 may facilitate the growth and lymph node metastasis of gastric signet cell carcinoma.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第1期63-65,F0003,共4页 Jiangsu Medical Journal
关键词 印戒细胞癌 P53 HER-2 Signet cell carcinoma p53 HER-2
  • 相关文献

参考文献8

  • 1Climent MA,Segui MA,Peiro G,et al.Prognostic value ofHER-2/neu and p53expression in node-positive breast cancer.HER-2/neu effect on adjuvant tamoxifen treatment[J].Breast,2001,10(2):67-77.
  • 2刘月仙,丁永斌,夏建国,陈国玉.复方丹参液联合顺铂抑制人胃癌生长的研究[J].江苏医药,2009,35(2):243-244. 被引量:1
  • 3Pinto-de-Sousa J,Silva F,David L,et al.Clinicopathologicalsignificance and survival influence of p53protein expression ingastric carcinoma[J].Histopathology.2004,44(4):323-331.
  • 4Garcia I,Vizoso F,Martin A,et al.Clinical significance of theepidermal growth factor receptor and HER-2receptor inresectable gastric cancer[J].Ann Surg Oncol,2003,10(3):234-241.
  • 5Risio M,De Rosa G,Sarotto I,et al.HER-2testing in gastriccancer:molecular morphology and storage time-related changesin archival samples[J].Int J Oncol.2003,23(5):1381-1387.
  • 6Oshima CT,Lanzoni VP,Iriya K,et al.C-erbB-2oncoproteinin gastric carcinoma:correlation with clinical stage and progno-sis[J].Int J Biol Markers,2001,16(4):250-254.
  • 7Carter W,Hoying J,Boswell C,et al.HER2/neu over-expres-sion induces endothelial cell retraction[J].Int J Cancer,2001,91(3):295-299.
  • 8李华,路平,张静,徐惠绵,王舒宝,陈峻青.Lymph Node Metastasis in Early Signet Ring Cell Carcinoma:Endoscopic Mucosal Resection[J].Chinese Journal of Cancer Research,2008,20(4):274-278. 被引量:1

二级参考文献18

  • 1郑国灿,李智英.丹参酮I抗肿瘤作用及作用机制的实验研究[J].实用肿瘤杂志,2005,20(1):33-35. 被引量:25
  • 2Makuuchi H, Kise Kise Y, Shimada H, et al. Endoscopic mucosal resection for early gastric cancer[J]. Sem Surg Oncol 1999; 17: 108-16.
  • 3Ishikawa S, Togshi A, Inoue M, et al. Indications for EMR/ESD in cases of early gastric cancer:relationship between histological type, depth of wall invasion, and lymph node metastasis[J]. Gastric Cancer 2007; 10: 35-8.
  • 4Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer[J]. J Gastroenterol 2006; 41: 929-42.
  • 5Hyung WJ, Cheong JH, Kim J, et al. Application of minimally invasive treatment for early gastric cancer[J]. J Surg Oncol 2004; 85: 181-5.
  • 6Abe N, Watanabe T, Sugiyama M, et al. Endoscopic treatment or surgery for undifferentiated early gastric cancer[J]? Am J Surg 2004; 188: 181-4.
  • 7Nasu J, Nishina T, Hirasaki S, et al. Predictive factors of lymph node metastasis in patients with undifferentiated early gastric cancers[J]. J Clin Gastroenterol 2006; 40: 412-5.
  • 8Japanese Gastric Cancer Association, Japanese classification of gastric carcinoma[M]. 2nd English ed. Gastric Cancer 1998; 1: 10-24.
  • 9Hyung WJ, Noh SH, Lee JH, et al. Early gastric carcinoma with signet ring cell histology[J]. Cancer 2002; 94: 78-83.
  • 10Kunisaki C, Shimada H, Nomura M, et al. Therapeutic strategy for signet ring cell carcinoma of the stomach[J]. Br J Surg 2004; 91: 1319-24.

同被引文献28

  • 1孙龙.胃印戒细胞癌66例临床病理学观察[J].吉林医学,2013,34(13):2523-2524. 被引量:2
  • 2叶志君,陈剑辉,王天宝,石汉平,蔡世荣,何裕隆,詹文华.胃黏液腺癌与胃印戒细胞癌的临床病理特征及预后的分析比较[J].消化肿瘤杂志(电子版),2010,2(2):102-107. 被引量:4
  • 3Hamilton SR,Aaltonen LA.虞积耀,崔全才主译.消化系统肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.295-297.
  • 4Tan X, Egami H, Nozawa F, et al. Analysis of the invasion metastasis mechanism in pancreatic cancer: involvement of plasminogen cascade proteins in the invasion of pancreatic cancer cells[J]. Int J Oncol, 2006,28(2) :369-374.
  • 5Reuning U, Sehmitt M, Luber B, et al. Methods to analyze the effects of the urokinase system on cancer cell adhesion, proliferation, migration, and signal transduction events [J]. Methods Mol Med , 2006,120 : 427-440.
  • 6Hildenbrand R, Gandhari M, Stroebel P, et al. The uroki- nase-system--role of cell proliferation and apoptosis[J]. Histol Histopathol, 2008,23(2) :227-236.
  • 7Kufe D W. Functional targeting of the MUC1 oncogene in hu- aaan cancer[J]. Cancer Biol Ther, 2009,8(13) : 1197-1203.
  • 8Mukhopadhyay P, Chakraborty S, Ponnusamy M P, et al Mucins in the pathogenesis of breast cancer: implications in di agnosis,prognosis and therapy[J]. Biochim Bioph ys Acta 2011,1815(2) :224-240.
  • 9Huang L, Chen D, Liu D, et al. MUC1 oncoprotein blocks glycogen synthase kinase 3 beta-mediated phosphorylation and degradation of beta-catenin [J]. Cancer Res, 2005, 65 (22) ]10413.
  • 10Wiman K G. Pharmacological reactivation of mutant p53: from protein structure to the cancer patient[J]. Oncogene, 2010,29(30) :4245-4252.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部